Back
Range Cancer Therapeutics ETF Stock Price Chart
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Buy
63
CNCR
Range Cancer Therapeutics ETF
Last Price:
15.58
Seasonality Move:
8.86%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNCR is experiencing slight selling pressure.
Range Cancer Therapeutics ETF Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.03 | Buy |
| 20-day SMA: | 15 | Buy |
| 50-day SMA: | 15.01 | Buy |
| 200-day SMA: | 15.06 | Buy |
| 8-day EMA: | 15.09 | Buy |
| 20-day EMA: | 15.01 | Buy |
| 50-day EMA: | 14.94 | Buy |
| 200-day EMA: | 14.59 | Buy |
Range Cancer Therapeutics ETF Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 59.34 | Buy |
| Chaikin Money Flow: | -127 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.63 - 15.23) | Buy |
| Bollinger Bands (100): | (14 - 15.38) | Buy |
Range Cancer Therapeutics ETF Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Range Cancer Therapeutics ETF Stock
Is Range Cancer Therapeutics ETF Stock a Buy?
- Range Cancer Therapeutics ETF share price is 15.59 while CNCR 8-day simple moving average is 15.03, which is a Buy signal.
- The stock price of CNCR is 15.59 while Range Cancer Therapeutics ETF 20-day SMA is 15.00, which makes it a Buy.
- Range Cancer Therapeutics ETF 50-day simple moving average is 15.01 while CNCR share price is 15.59, making it a Buy technically.
- CNCR stock price is 15.59 and Range Cancer Therapeutics ETF 200-day simple moving average is 15.06, creating a Buy signal.
CNCR Technical Analysis vs Fundamental Analysis
Buy
63
Range Cancer Therapeutics ETF (CNCR)
is a Buy
Is Range Cancer Therapeutics ETF a Buy or a Sell?
-
Range Cancer Therapeutics ETF stock is rated a Buy
The current Range Cancer Therapeutics ETF [CNCR] share price is $15.59. The Score for CNCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Range Cancer Therapeutics ETF Stock Info
Market Cap:
0
Price in USD:
15.59
Share Volume:
3.1K
Range Cancer Therapeutics ETF 52-Week Range
52-Week High:
17.96
52-Week Low:
9.52
Buy
63
Range Cancer Therapeutics ETF (CNCR)
is a Buy
Range Cancer Therapeutics ETF Share Price Forecast
-
What is the Range Cancer Therapeutics ETF stock price today?
The Range Cancer Therapeutics ETF stock price is 15.59 USD today. -
Will CNCR stock go up or go down?
Range Cancer Therapeutics ETF> share price is forecast to RISE/FALL based on technical indicators -
Is Range Cancer Therapeutics ETF overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Range Cancer Therapeutics ETF is not overvalued.
Is Range Cancer Therapeutics ETF Stock a Buy?
- Range Cancer Therapeutics ETF share price is 15.59 while CNCR 8-day exponential moving average is 15.09, which is a Buy signal.
- The stock price of CNCR is 15.59 while Range Cancer Therapeutics ETF 20-day EMA is 15.01, which makes it a Buy.
- Range Cancer Therapeutics ETF 50-day exponential moving average is 14.94 while CNCR share price is 15.59, making it a Buy technically.
- CNCR stock price is 15.59 and Range Cancer Therapeutics ETF 200-day simple moving average is 14.59, creating a Buy signal.
Technical Analysis of Range Cancer Therapeutics ETF
Should I short Range Cancer Therapeutics ETF stock?
- CNCR Moving Average Covergence Divergence (MACD) indicator is 0.05, suggesting Range Cancer Therapeutics ETF is a Buy
- Range Cancer Therapeutics ETF Relative Strength Index (RSI) is 59.34, which suggest Range Cancer Therapeutics ETF is overbought
- The Bollinger Bands (25) for Range Cancer Therapeutics ETF is (14.63 - 15.23), which suggest Range Cancer Therapeutics ETF is a Buy
- The Bollinger Bands (100) for Range Cancer Therapeutics ETF is (14 - 15.38), which suggest Range Cancer Therapeutics ETF is a Buy
* Range Cancer Therapeutics ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.